2 most recent filings and news items mentioning CNTY. Updated every 60 seconds.
RegulatoryJun 8, 2026Positive
Century Therapeutics announced new preclinical data for CNTY-813, an iPSC-derived islet replacement therapy that demonstrated durable glucose control for over eight months and immune evasion without immunosuppression in preclinical models. The company plans to submit an IND appli
View filing at SEC.gov →
RegulatoryMay 28, 2026Positive
Grant Thornton LLP, the company's auditor, has reviewed and agreed with Century Casinos' Form 8-K Item 4.01 filing regarding changes in accountants dated May 28, 2026. This confirmation indicates a smooth transition in auditor representation for the casino operator.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.